#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Aline Miller
1-1	0-5	Aline	organization[1]	new[1]	coref	2-1[2_1]
1-2	6-12	Miller	organization[1]	new[1]	_	_

#Text=Aline Fiona Miller is a Professor of Biomolecular Engineering at the University of Manchester .
2-1	13-18	Aline	organization[2]	giv[2]	coref	2-5[3_2]
2-2	19-24	Fiona	organization[2]	giv[2]	_	_
2-3	25-31	Miller	organization[2]	giv[2]	_	_
2-4	32-34	is	_	_	_	_
2-5	35-36	a	organization[3]	giv[3]	ana	3-1[0_3]
2-6	37-46	Professor	organization[3]	giv[3]	_	_
2-7	47-49	of	organization[3]	giv[3]	_	_
2-8	50-62	Biomolecular	organization[3]|abstract[4]	giv[3]|new[4]	coref	20-5[141_4]
2-9	63-74	Engineering	organization[3]|abstract[4]	giv[3]|new[4]	_	_
2-10	75-77	at	organization[3]	giv[3]	_	_
2-11	78-81	the	organization[3]|organization[5]	giv[3]|new[5]	coref	28-8[204_5]
2-12	82-92	University	organization[3]|organization[5]	giv[3]|new[5]	_	_
2-13	93-95	of	organization[3]|organization[5]	giv[3]|new[5]	_	_
2-14	96-106	Manchester	organization[3]|organization[5]|place	giv[3]|new[5]|new	coref	12-6
2-15	107-108	.	_	_	_	_

#Text=She specialises in the characterisation of polymer , biopolymer and peptides , using neutron and x-ray scattering , as well as the development of functionalised nanostructures for regenerative medicine and toxicology testing .
3-1	109-112	She	organization	giv	coref	5-1
3-2	113-124	specialises	_	_	_	_
3-3	125-127	in	_	_	_	_
3-4	128-131	the	abstract[8]	new[8]	_	_
3-5	132-148	characterisation	abstract[8]	new[8]	_	_
3-6	149-151	of	abstract[8]	new[8]	_	_
3-7	152-159	polymer	abstract[8]|substance	new[8]|new	coref	18-8
3-8	160-161	,	abstract[8]	new[8]	_	_
3-9	162-172	biopolymer	abstract[8]|substance	new[8]|new	coref	18-10
3-10	173-176	and	abstract[8]	new[8]	_	_
3-11	177-185	peptides	abstract[8]|substance	new[8]|new	coref	18-12
3-12	186-187	,	abstract[8]	new[8]	_	_
3-13	188-193	using	abstract[8]	new[8]	_	_
3-14	194-201	neutron	abstract[8]|substance|abstract[14]	new[8]|new|new[14]	coref|coref	18-15|18-15[133_14]
3-15	202-205	and	abstract[8]|abstract[14]	new[8]|new[14]	_	_
3-16	206-211	x-ray	abstract[8]|object|abstract[14]	new[8]|new|new[14]	coref	18-17
3-17	212-222	scattering	abstract[8]|abstract[14]	new[8]|new[14]	_	_
3-18	223-224	,	abstract[8]	new[8]	_	_
3-19	225-227	as	abstract[8]	new[8]	_	_
3-20	228-232	well	abstract[8]	new[8]	_	_
3-21	233-235	as	abstract[8]	new[8]	_	_
3-22	236-239	the	abstract[8]|event[15]	new[8]|new[15]	_	_
3-23	240-251	development	abstract[8]|event[15]	new[8]|new[15]	_	_
3-24	252-254	of	abstract[8]|event[15]	new[8]|new[15]	_	_
3-25	255-269	functionalised	abstract[8]|event[15]|object[16]	new[8]|new[15]|new[16]	_	_
3-26	270-284	nanostructures	abstract[8]|event[15]|object[16]	new[8]|new[15]|new[16]	_	_
3-27	285-288	for	abstract[8]|event[15]|object[16]	new[8]|new[15]|new[16]	_	_
3-28	289-301	regenerative	abstract[8]|event[15]|object[16]|abstract[17]	new[8]|new[15]|new[16]|new[17]	_	_
3-29	302-310	medicine	abstract[8]|event[15]|object[16]|abstract[17]	new[8]|new[15]|new[16]|new[17]	_	_
3-30	311-314	and	abstract[8]|event[15]|object[16]	new[8]|new[15]|new[16]	_	_
3-31	315-325	toxicology	abstract[8]|event[15]|object[16]|abstract|abstract[19]	new[8]|new[15]|new[16]|new|new[19]	_	_
3-32	326-333	testing	abstract[8]|event[15]|object[16]|abstract[19]	new[8]|new[15]|new[16]|new[19]	_	_
3-33	334-335	.	_	_	_	_

#Text=Early life and education
4-1	336-341	Early	abstract[20]	new[20]	_	_
4-2	342-346	life	abstract[20]	new[20]	_	_
4-3	347-350	and	_	_	_	_
4-4	351-360	education	abstract	new	_	_

#Text=Miller studied Chemistry at the University of Strathclyde and graduated in 1997 . [ 2 ]
5-1	361-367	Miller	organization	giv	ana	6-1
5-2	368-375	studied	_	_	_	_
5-3	376-385	Chemistry	abstract	new	coref	46-4
5-4	386-388	at	_	_	_	_
5-5	389-392	the	organization[24]	new[24]	coref	7-3[36_24]
5-6	393-403	University	organization[24]	new[24]	_	_
5-7	404-406	of	organization[24]	new[24]	_	_
5-8	407-418	Strathclyde	organization[24]|person	new[24]|new	coref	35-4
5-9	419-422	and	_	_	_	_
5-10	423-432	graduated	_	_	_	_
5-11	433-435	in	_	_	_	_
5-12	436-440	1997	time	new	_	_
5-13	441-442	.	_	_	_	_
5-14	443-444	[	_	_	_	_
5-15	445-446	2	abstract	new	coref	6-14
5-16	447-448	]	_	_	_	_

#Text=She was an undergraduate exchange student at Franklin & Marshall College . [ 2 ]
6-1	449-452	She	organization	giv	coref	6-3[30_0]
6-2	453-456	was	_	_	_	_
6-3	457-459	an	organization[30]	giv[30]	coref	7-1[0_30]
6-4	460-473	undergraduate	organization[30]	giv[30]	_	_
6-5	474-482	exchange	organization|organization[30]	new|giv[30]	_	_
6-6	483-490	student	organization[30]	giv[30]	_	_
6-7	491-493	at	organization[30]	giv[30]	_	_
6-8	494-502	Franklin	organization[30]|place|organization[32]	giv[30]|new|new[32]	_	_
6-9	503-504	&	organization[30]|organization[32]	giv[30]|new[32]	_	_
6-10	505-513	Marshall	organization[30]|organization[32]	giv[30]|new[32]	_	_
6-11	514-521	College	organization[30]|organization[32]	giv[30]|new[32]	_	_
6-12	522-523	.	_	_	_	_
6-13	524-525	[	_	_	_	_
6-14	526-527	2	abstract	giv	coref	7-24
6-15	528-529	]	_	_	_	_

#Text=Miller joined Durham University as a post graduate student , earning a PhD in 2000 under the supervision of Randal Richards . [ 2 ]
7-1	530-536	Miller	organization	giv	coref	7-6[37_0]
7-2	537-543	joined	_	_	_	_
7-3	544-550	Durham	place|organization[36]	new|giv[36]	_	_
7-4	551-561	University	organization[36]	giv[36]	_	_
7-5	562-564	as	_	_	_	_
7-6	565-566	a	organization[37]	giv[37]	coref	8-1[0_37]
7-7	567-571	post	organization[37]	giv[37]	_	_
7-8	572-580	graduate	organization[37]	giv[37]	_	_
7-9	581-588	student	organization[37]	giv[37]	_	_
7-10	589-590	,	_	_	_	_
7-11	591-598	earning	_	_	_	_
7-12	599-600	a	abstract[38]	new[38]	_	_
7-13	601-604	PhD	abstract[38]	new[38]	_	_
7-14	605-607	in	_	_	_	_
7-15	608-612	2000	time	new	_	_
7-16	613-618	under	_	_	_	_
7-17	619-622	the	abstract[40]	new[40]	_	_
7-18	623-634	supervision	abstract[40]	new[40]	_	_
7-19	635-637	of	abstract[40]	new[40]	_	_
7-20	638-644	Randal	abstract[40]|person[41]	new[40]|new[41]	_	_
7-21	645-653	Richards	abstract[40]|person[41]	new[40]|new[41]	_	_
7-22	654-655	.	_	_	_	_
7-23	656-657	[	_	_	_	_
7-24	658-659	2	abstract	giv	coref	13-11
7-25	660-661	]	_	_	_	_

#Text=Miller worked on graft copolymers , which included polynorbornene and poly(ethylene oxide ) , and studied their organisation at air-water interfaces . [ 1 ]
8-1	662-668	Miller	organization	giv	ana	9-3
8-2	669-675	worked	_	_	_	_
8-3	676-678	on	_	_	_	_
8-4	679-684	graft	abstract|abstract[45]	new|new[45]	_	_
8-5	685-695	copolymers	abstract[45]	new[45]	_	_
8-6	696-697	,	abstract[45]	new[45]	_	_
8-7	698-703	which	abstract[45]	new[45]	_	_
8-8	704-712	included	abstract[45]	new[45]	_	_
8-9	713-727	polynorbornene	abstract[45]|substance|substance[47]	new[45]|new|new[47]	ana	8-17[0_47]
8-10	728-731	and	abstract[45]|substance[47]	new[45]|new[47]	_	_
8-11	732-745	poly(ethylene	abstract[45]|substance[47]|substance|substance[49]	new[45]|new[47]|new|new[49]	_	_
8-12	746-751	oxide	abstract[45]|substance[47]|substance[49]	new[45]|new[47]|new[49]	_	_
8-13	752-753	)	_	_	_	_
8-14	754-755	,	_	_	_	_
8-15	756-759	and	_	_	_	_
8-16	760-767	studied	_	_	_	_
8-17	768-773	their	substance|abstract[51]	giv|new[51]	_	_
8-18	774-786	organisation	abstract[51]	new[51]	_	_
8-19	787-789	at	_	_	_	_
8-20	790-799	air-water	place|abstract[53]	new|new[53]	coref	14-10[95_53]
8-21	800-810	interfaces	abstract[53]	new[53]	_	_
8-22	811-812	.	_	_	_	_
8-23	813-814	[	_	_	_	_
8-24	815-816	1	abstract	new	_	_
8-25	817-818	]	_	_	_	_

#Text=After completing her doctorate , Miller moved to New Hall College at the University of Cambridge , where she was appointed a Junior Research Fellow and she worked with Athene Donald on cellulose . [ 3 ] [ 4 ] [ 5 ] [ 6 ]
9-1	819-824	After	_	_	_	_
9-2	825-835	completing	_	_	_	_
9-3	836-839	her	organization|abstract[56]	giv|new[56]	coref	9-6
9-4	840-849	doctorate	abstract[56]	new[56]	_	_
9-5	850-851	,	_	_	_	_
9-6	852-858	Miller	organization	giv	ana	9-19
9-7	859-864	moved	_	_	_	_
9-8	865-867	to	_	_	_	_
9-9	868-871	New	organization[59]	new[59]	_	_
9-10	872-876	Hall	place|organization[59]	new|new[59]	coref	41-2[277_0]
9-11	877-884	College	organization[59]	new[59]	_	_
9-12	885-887	at	organization[59]	new[59]	_	_
9-13	888-891	the	organization[59]|organization[60]	new[59]|new[60]	_	_
9-14	892-902	University	organization[59]|organization[60]	new[59]|new[60]	_	_
9-15	903-905	of	organization[59]|organization[60]	new[59]|new[60]	_	_
9-16	906-915	Cambridge	organization[59]|organization[60]|place	new[59]|new[60]|new	_	_
9-17	916-917	,	organization[59]	new[59]	_	_
9-18	918-923	where	organization[59]	new[59]	_	_
9-19	924-927	she	organization[59]|organization	new[59]|giv	ana	9-27
9-20	928-931	was	organization[59]	new[59]	_	_
9-21	932-941	appointed	organization[59]	new[59]	_	_
9-22	942-943	a	organization[59]|person[64]	new[59]|new[64]	_	_
9-23	944-950	Junior	organization[59]|person[64]	new[59]|new[64]	_	_
9-24	951-959	Research	organization[59]|organization|person[64]	new[59]|new|new[64]	coref	10-9
9-25	960-966	Fellow	organization[59]|person[64]	new[59]|new[64]	_	_
9-26	967-970	and	organization[59]	new[59]	_	_
9-27	971-974	she	organization[59]|organization	new[59]|giv	coref	12-1
9-28	975-981	worked	organization[59]	new[59]	_	_
9-29	982-986	with	_	_	_	_
9-30	987-993	Athene	person[66]	new[66]	ana	10-1[0_66]
9-31	994-1000	Donald	person[66]	new[66]	_	_
9-32	1001-1003	on	_	_	_	_
9-33	1004-1013	cellulose	substance	new	_	_
9-34	1014-1015	.	_	_	_	_
9-35	1016-1017	[	_	_	_	_
9-36	1018-1019	3	abstract	new	coref	17-16
9-37	1020-1021	]	_	_	_	_
9-38	1022-1023	[	_	_	_	_
9-39	1024-1025	4	abstract	new	_	_
9-40	1026-1027	]	_	_	_	_
9-41	1028-1029	[	_	_	_	_
9-42	1030-1031	5	abstract	new	_	_
9-43	1032-1033	]	_	_	_	_
9-44	1034-1035	[	_	_	_	_
9-45	1036-1037	6	abstract	new	_	_
9-46	1038-1039	]	_	_	_	_

#Text=She was inspired to have a career in research during this fellowship . [ 7 ]
10-1	1040-1043	She	person	giv	_	_
10-2	1044-1047	was	_	_	_	_
10-3	1048-1056	inspired	_	_	_	_
10-4	1057-1059	to	_	_	_	_
10-5	1060-1064	have	_	_	_	_
10-6	1065-1066	a	abstract[73]	new[73]	coref	11-3[0_73]
10-7	1067-1073	career	abstract[73]	new[73]	_	_
10-8	1074-1076	in	abstract[73]	new[73]	_	_
10-9	1077-1085	research	abstract[73]|organization	new[73]|giv	coref	11-1
10-10	1086-1092	during	_	_	_	_
10-11	1093-1097	this	abstract[75]	new[75]	_	_
10-12	1098-1108	fellowship	abstract[75]	new[75]	_	_
10-13	1109-1110	.	_	_	_	_
10-14	1111-1112	[	_	_	_	_
10-15	1113-1114	7	abstract	new	_	_
10-16	1115-1116	]	_	_	_	_

#Text=Research and career
11-1	1117-1125	Research	organization	giv	coref	17-12
11-2	1126-1129	and	_	_	_	_
11-3	1130-1136	career	abstract	giv	_	_

#Text=Miller joined the University of Manchester Institute of Science and Technology ( UMIST ) in 2002 . [ 8 ]
12-1	1137-1143	Miller	organization	giv	ana	13-1
12-2	1144-1150	joined	_	_	_	_
12-3	1151-1154	the	organization[82]	new[82]	_	_
12-4	1155-1165	University	organization[80]|organization[82]	new[80]|new[82]	coref	17-6[119_80]
12-5	1166-1168	of	organization[80]|organization[82]	new[80]|new[82]	_	_
12-6	1169-1179	Manchester	organization[80]|place|organization[82]	new[80]|giv|new[82]	coref	17-8
12-7	1180-1189	Institute	organization[82]	new[82]	_	_
12-8	1190-1192	of	organization[82]	new[82]	_	_
12-9	1193-1200	Science	organization[82]|organization	new[82]|new	_	_
12-10	1201-1204	and	organization[82]	new[82]	_	_
12-11	1205-1215	Technology	organization[82]|abstract	new[82]|new	_	_
12-12	1216-1217	(	_	_	_	_
12-13	1218-1223	UMIST	organization	new	_	_
12-14	1224-1225	)	_	_	_	_
12-15	1226-1228	in	_	_	_	_
12-16	1229-1233	2002	time	new	_	_
12-17	1234-1235	.	_	_	_	_
12-18	1236-1237	[	_	_	_	_
12-19	1238-1239	8	abstract	new	coref	16-22
12-20	1240-1241	]	_	_	_	_

#Text=She was made a full Professor in 2014 . [ 2 ]
13-1	1242-1245	She	organization	giv	coref	13-4[89_0]
13-2	1246-1249	was	_	_	_	_
13-3	1250-1254	made	_	_	_	_
13-4	1255-1256	a	organization[89]	giv[89]	ana	14-1[0_89]
13-5	1257-1261	full	organization[89]	giv[89]	_	_
13-6	1262-1271	Professor	organization[89]	giv[89]	_	_
13-7	1272-1274	in	_	_	_	_
13-8	1275-1279	2014	time	new	_	_
13-9	1280-1281	.	_	_	_	_
13-10	1282-1283	[	_	_	_	_
13-11	1284-1285	2	abstract	giv	_	_
13-12	1286-1287	]	_	_	_	_

#Text=She continued to investigate the behaviour of molecules at different interfaces , including the air-liquid and liquid-liquid interface .
14-1	1288-1291	She	organization	giv	coref	16-13
14-2	1292-1301	continued	_	_	_	_
14-3	1302-1304	to	_	_	_	_
14-4	1305-1316	investigate	_	_	_	_
14-5	1317-1320	the	abstract[93]	new[93]	_	_
14-6	1321-1330	behaviour	abstract[93]	new[93]	_	_
14-7	1331-1333	of	abstract[93]	new[93]	_	_
14-8	1334-1343	molecules	abstract[93]|object[94]	new[93]|new[94]	coref	15-14[100_94]
14-9	1344-1346	at	abstract[93]|object[94]	new[93]|new[94]	_	_
14-10	1347-1356	different	abstract[93]|object[94]|abstract[95]	new[93]|new[94]|giv[95]	_	_
14-11	1357-1367	interfaces	abstract[93]|object[94]|abstract[95]	new[93]|new[94]|giv[95]	_	_
14-12	1368-1369	,	abstract[93]	new[93]	_	_
14-13	1370-1379	including	abstract[93]	new[93]	_	_
14-14	1380-1383	the	abstract[93]	new[93]	_	_
14-15	1384-1394	air-liquid	abstract[93]	new[93]	_	_
14-16	1395-1398	and	abstract[93]	new[93]	_	_
14-17	1399-1412	liquid-liquid	abstract[93]	new[93]	_	_
14-18	1413-1422	interface	abstract[93]|abstract	new[93]|new	_	_
14-19	1423-1424	.	_	_	_	_

#Text=Surfactants and polymers can be used to promote or inhibit the crystallisation of small molecules , for example the use of hydroxyl based polymers in the crystallisation of ice cream .
15-1	1425-1436	Surfactants	substance	new	_	_
15-2	1437-1440	and	_	_	_	_
15-3	1441-1449	polymers	substance	new	coref	15-22[103_0]
15-4	1450-1453	can	_	_	_	_
15-5	1454-1456	be	_	_	_	_
15-6	1457-1461	used	_	_	_	_
15-7	1462-1464	to	_	_	_	_
15-8	1465-1472	promote	_	_	_	_
15-9	1473-1475	or	_	_	_	_
15-10	1476-1483	inhibit	_	_	_	_
15-11	1484-1487	the	substance[99]	new[99]	_	_
15-12	1488-1503	crystallisation	substance[99]	new[99]	_	_
15-13	1504-1506	of	substance[99]	new[99]	_	_
15-14	1507-1512	small	substance[99]|object[100]	new[99]|giv[100]	_	_
15-15	1513-1522	molecules	substance[99]|object[100]	new[99]|giv[100]	_	_
15-16	1523-1524	,	_	_	_	_
15-17	1525-1528	for	_	_	_	_
15-18	1529-1536	example	event[101]	new[101]	_	_
15-19	1537-1540	the	event[101]	new[101]	_	_
15-20	1541-1544	use	event[101]	new[101]	_	_
15-21	1545-1547	of	event[101]	new[101]	_	_
15-22	1548-1556	hydroxyl	event[101]|abstract|substance[103]	new[101]|new|giv[103]	coref	17-9[0_103]
15-23	1557-1562	based	event[101]|substance[103]	new[101]|giv[103]	_	_
15-24	1563-1571	polymers	event[101]|substance[103]	new[101]|giv[103]	_	_
15-25	1572-1574	in	event[101]|substance[103]	new[101]|giv[103]	_	_
15-26	1575-1578	the	event[101]|substance[103]|substance[104]	new[101]|giv[103]|new[104]	_	_
15-27	1579-1594	crystallisation	event[101]|substance[103]|substance[104]	new[101]|giv[103]|new[104]	_	_
15-28	1595-1597	of	event[101]|substance[103]|substance[104]	new[101]|giv[103]|new[104]	_	_
15-29	1598-1601	ice	event[101]|substance[103]|substance[104]|place[105]	new[101]|giv[103]|new[104]|new[105]	_	_
15-30	1602-1607	cream	event[101]|substance[103]|substance[104]|place[105]	new[101]|giv[103]|new[104]|new[105]	_	_
15-31	1608-1609	.	_	_	_	_

#Text=To mimic how fish use macromolecules to stop their blood freezing , Miller combines antifreeze proteins with ice crystals . [ 8 ]
16-1	1610-1612	To	_	_	_	_
16-2	1613-1618	mimic	_	_	_	_
16-3	1619-1622	how	_	_	_	_
16-4	1623-1627	fish	animal	new	_	_
16-5	1628-1631	use	_	_	_	_
16-6	1632-1646	macromolecules	animal	new	ana	16-9
16-7	1647-1649	to	_	_	_	_
16-8	1650-1654	stop	_	_	_	_
16-9	1655-1660	their	animal|substance[109]	giv|new[109]	_	_
16-10	1661-1666	blood	substance[109]	new[109]	_	_
16-11	1667-1675	freezing	event	new	_	_
16-12	1676-1677	,	_	_	_	_
16-13	1678-1684	Miller	organization	giv	coref	17-3
16-14	1685-1693	combines	_	_	_	_
16-15	1694-1704	antifreeze	abstract|substance[113]	new|new[113]	coref	20-15[0_113]
16-16	1705-1713	proteins	substance[113]	new[113]	_	_
16-17	1714-1718	with	_	_	_	_
16-18	1719-1722	ice	substance|object[115]	new|new[115]	_	_
16-19	1723-1731	crystals	object[115]	new[115]	_	_
16-20	1732-1733	.	_	_	_	_
16-21	1734-1735	[	_	_	_	_
16-22	1736-1737	8	abstract	giv	coref	19-17
16-23	1738-1739	]	_	_	_	_

#Text=In 2004 Miller established the University of Manchester Polymers & Peptides Research Group . [ 3 ]
17-1	1740-1742	In	_	_	_	_
17-2	1743-1747	2004	time	new	_	_
17-3	1748-1754	Miller	organization	giv	ana	18-2
17-4	1755-1766	established	_	_	_	_
17-5	1767-1770	the	organization[124]	new[124]	coref	44-1[290_124]
17-6	1771-1781	University	organization[119]|organization[124]	giv[119]|new[124]	_	_
17-7	1782-1784	of	organization[119]|organization[124]	giv[119]|new[124]	_	_
17-8	1785-1795	Manchester	organization[119]|place|organization[124]	giv[119]|giv|new[124]	coref	28-11
17-9	1796-1804	Polymers	substance|organization[124]	giv|new[124]	coref	24-8[177_0]
17-10	1805-1806	&	place[122]|organization[124]	new[122]|new[124]	_	_
17-11	1807-1815	Peptides	place[122]|organization[124]	new[122]|new[124]	_	_
17-12	1816-1824	Research	organization|organization[124]	giv|new[124]	coref	38-6
17-13	1825-1830	Group	organization[124]	new[124]	_	_
17-14	1831-1832	.	_	_	_	_
17-15	1833-1834	[	_	_	_	_
17-16	1835-1836	3	abstract	giv	coref	23-27
17-17	1837-1838	]	_	_	_	_

#Text=Here she works on the characterisation of polymer , biopolymer and peptides , using neutron and x-ray scattering .
18-1	1839-1843	Here	_	_	_	_
18-2	1844-1847	she	organization	giv	coref	19-8
18-3	1848-1853	works	_	_	_	_
18-4	1854-1856	on	_	_	_	_
18-5	1857-1860	the	abstract[127]	new[127]	_	_
18-6	1861-1877	characterisation	abstract[127]	new[127]	_	_
18-7	1878-1880	of	abstract[127]	new[127]	_	_
18-8	1881-1888	polymer	abstract[127]|substance	new[127]|giv	_	_
18-9	1889-1890	,	abstract[127]	new[127]	_	_
18-10	1891-1901	biopolymer	abstract[127]|substance	new[127]|giv	_	_
18-11	1902-1905	and	abstract[127]	new[127]	_	_
18-12	1906-1914	peptides	abstract[127]|substance	new[127]|giv	coref	20-17
18-13	1915-1916	,	_	_	_	_
18-14	1917-1922	using	_	_	_	_
18-15	1923-1930	neutron	substance|abstract[133]	giv|giv[133]	_	_
18-16	1931-1934	and	abstract[133]	giv[133]	_	_
18-17	1935-1940	x-ray	object|abstract[133]	giv|giv[133]	_	_
18-18	1941-1951	scattering	abstract[133]	giv[133]	_	_
18-19	1952-1953	.	_	_	_	_

#Text=The in-depth characterisation of these materials allows Miller to tailor them for specific applications . [ 8 ]
19-1	1954-1957	The	abstract[134]	new[134]	_	_
19-2	1958-1966	in-depth	abstract[134]	new[134]	_	_
19-3	1967-1983	characterisation	abstract[134]	new[134]	_	_
19-4	1984-1986	of	abstract[134]	new[134]	_	_
19-5	1987-1992	these	abstract[134]|substance[135]	new[134]|new[135]	ana	19-11[0_135]
19-6	1993-2002	materials	abstract[134]|substance[135]	new[134]|new[135]	_	_
19-7	2003-2009	allows	_	_	_	_
19-8	2010-2016	Miller	organization	giv	coref	20-1
19-9	2017-2019	to	_	_	_	_
19-10	2020-2026	tailor	_	_	_	_
19-11	2027-2031	them	substance	giv	coref	27-8[200_0]
19-12	2032-2035	for	_	_	_	_
19-13	2036-2044	specific	abstract[138]	new[138]	_	_
19-14	2045-2057	applications	abstract[138]	new[138]	_	_
19-15	2058-2059	.	_	_	_	_
19-16	2060-2061	[	_	_	_	_
19-17	2062-2063	8	abstract	giv	coref	20-20
19-18	2064-2065	]	_	_	_	_

#Text=Miller also works in biomedical engineering , creating three-dimensional scaffolds through the control of proteins and peptides . [ 8 ] [ 9 ]
20-1	2066-2072	Miller	organization	giv	ana	21-1
20-2	2073-2077	also	_	_	_	_
20-3	2078-2083	works	_	_	_	_
20-4	2084-2086	in	_	_	_	_
20-5	2087-2097	biomedical	abstract[141]	giv[141]	coref	48-6[0_141]
20-6	2098-2109	engineering	abstract[141]	giv[141]	_	_
20-7	2110-2111	,	_	_	_	_
20-8	2112-2120	creating	_	_	_	_
20-9	2121-2138	three-dimensional	object[142]	new[142]	_	_
20-10	2139-2148	scaffolds	object[142]	new[142]	_	_
20-11	2149-2156	through	_	_	_	_
20-12	2157-2160	the	abstract[143]	new[143]	_	_
20-13	2161-2168	control	abstract[143]	new[143]	_	_
20-14	2169-2171	of	abstract[143]	new[143]	_	_
20-15	2172-2180	proteins	abstract[143]|substance|substance[145]	new[143]|giv|giv[145]	coref|coref	20-15[145_0]|22-5[0_145]
20-16	2181-2184	and	abstract[143]|substance[145]	new[143]|giv[145]	_	_
20-17	2185-2193	peptides	abstract[143]|substance[145]|substance	new[143]|giv[145]|giv	coref	24-1[176_0]
20-18	2194-2195	.	_	_	_	_
20-19	2196-2197	[	_	_	_	_
20-20	2198-2199	8	abstract	giv	_	_
20-21	2200-2201	]	_	_	_	_
20-22	2202-2203	[	_	_	_	_
20-23	2204-2205	9	abstract	new	_	_
20-24	2206-2207	]	_	_	_	_

#Text=She explores the relationship between mesoscopic structure , material properties and cell response . [ 10 ] [ 11 ]
21-1	2208-2211	She	organization	giv	ana	22-1
21-2	2212-2220	explores	_	_	_	_
21-3	2221-2224	the	abstract[150]	new[150]	_	_
21-4	2225-2237	relationship	abstract[150]	new[150]	_	_
21-5	2238-2245	between	abstract[150]	new[150]	_	_
21-6	2246-2256	mesoscopic	abstract[150]|abstract[151]	new[150]|new[151]	_	_
21-7	2257-2266	structure	abstract[150]|abstract[151]	new[150]|new[151]	_	_
21-8	2267-2268	,	abstract[150]	new[150]	_	_
21-9	2269-2277	material	abstract[150]|substance|abstract[153]	new[150]|new|new[153]	coref|coref	23-9[170_153]|26-19[194_0]
21-10	2278-2288	properties	abstract[150]|abstract[153]	new[150]|new[153]	_	_
21-11	2289-2292	and	abstract[150]	new[150]	_	_
21-12	2293-2297	cell	abstract[150]|place|abstract[155]	new[150]|new|new[155]	_	_
21-13	2298-2306	response	abstract[150]|abstract[155]	new[150]|new[155]	_	_
21-14	2307-2308	.	_	_	_	_
21-15	2309-2310	[	_	_	_	_
21-16	2311-2313	10	abstract	new	_	_
21-17	2314-2315	]	_	_	_	_
21-18	2316-2317	[	_	_	_	_
21-19	2318-2320	11	abstract	new	_	_
21-20	2321-2322	]	_	_	_	_

#Text=She has studied how proteins self-assemble , including what causes them to unfold and form fibril structures . [ 12 ] [ 13 ] [ 14 ]
22-1	2323-2326	She	organization	giv	coref	25-13
22-2	2327-2330	has	_	_	_	_
22-3	2331-2338	studied	_	_	_	_
22-4	2339-2342	how	_	_	_	_
22-5	2343-2351	proteins	substance	giv	ana	22-11
22-6	2352-2365	self-assemble	_	_	_	_
22-7	2366-2367	,	_	_	_	_
22-8	2368-2377	including	_	_	_	_
22-9	2378-2382	what	_	_	_	_
22-10	2383-2389	causes	_	_	_	_
22-11	2390-2394	them	substance	giv	_	_
22-12	2395-2397	to	_	_	_	_
22-13	2398-2404	unfold	_	_	_	_
22-14	2405-2408	and	_	_	_	_
22-15	2409-2413	form	_	_	_	_
22-16	2414-2420	fibril	abstract|abstract[162]	new|new[162]	_	_
22-17	2421-2431	structures	abstract[162]	new[162]	_	_
22-18	2432-2433	.	_	_	_	_
22-19	2434-2435	[	_	_	_	_
22-20	2436-2438	12	abstract	new	_	_
22-21	2439-2440	]	_	_	_	_
22-22	2441-2442	[	_	_	_	_
22-23	2443-2445	13	abstract	new	_	_
22-24	2446-2447	]	_	_	_	_
22-25	2448-2449	[	_	_	_	_
22-26	2450-2452	14	abstract	new	_	_
22-27	2453-2454	]	_	_	_	_

#Text=The morphology ( roughness , porosity ) and mechanical properties ( such as Young 's modulus and viscosity ) can be controlled through self-assembly . [ 3 ]
23-1	2455-2458	The	abstract[166]	new[166]	appos	23-4[0_166]
23-2	2459-2469	morphology	abstract[166]	new[166]	_	_
23-3	2470-2471	(	_	_	_	_
23-4	2472-2481	roughness	abstract|abstract[168]	giv|giv[168]	appos|appos	23-4[168_0]|23-6[0_168]
23-5	2482-2483	,	abstract[168]	giv[168]	_	_
23-6	2484-2492	porosity	abstract[168]|abstract	giv[168]|giv	_	_
23-7	2493-2494	)	_	_	_	_
23-8	2495-2498	and	_	_	_	_
23-9	2499-2509	mechanical	abstract[170]	giv[170]	_	_
23-10	2510-2520	properties	abstract[170]	giv[170]	_	_
23-11	2521-2522	(	abstract[170]	giv[170]	_	_
23-12	2523-2527	such	abstract[170]	giv[170]	_	_
23-13	2528-2530	as	abstract[170]	giv[170]	_	_
23-14	2531-2536	Young	abstract[170]|place[171]|abstract[172]	giv[170]|new[171]|new[172]	_	_
23-15	2537-2539	's	abstract[170]|place[171]|abstract[172]	giv[170]|new[171]|new[172]	_	_
23-16	2540-2547	modulus	abstract[170]|abstract[172]	giv[170]|new[172]	_	_
23-17	2548-2551	and	abstract[170]	giv[170]	_	_
23-18	2552-2561	viscosity	abstract[170]|abstract	giv[170]|new	_	_
23-19	2562-2563	)	abstract[170]	giv[170]	_	_
23-20	2564-2567	can	_	_	_	_
23-21	2568-2570	be	_	_	_	_
23-22	2571-2581	controlled	_	_	_	_
23-23	2582-2589	through	_	_	_	_
23-24	2590-2603	self-assembly	abstract	new	coref	25-17[186_0]
23-25	2604-2605	.	_	_	_	_
23-26	2606-2607	[	_	_	_	_
23-27	2608-2609	3	abstract	giv	_	_
23-28	2610-2611	]	_	_	_	_

#Text=The self-assembling peptides can be conjugated with polymers that are sensitive to pH and temperature .
24-1	2612-2615	The	substance[176]	giv[176]	coref	25-5[181_176]
24-2	2616-2631	self-assembling	substance[176]	giv[176]	_	_
24-3	2632-2640	peptides	substance[176]	giv[176]	_	_
24-4	2641-2644	can	_	_	_	_
24-5	2645-2647	be	_	_	_	_
24-6	2648-2658	conjugated	_	_	_	_
24-7	2659-2663	with	_	_	_	_
24-8	2664-2672	polymers	substance[177]	giv[177]	_	_
24-9	2673-2677	that	substance[177]	giv[177]	_	_
24-10	2678-2681	are	substance[177]	giv[177]	_	_
24-11	2682-2691	sensitive	substance[177]	giv[177]	_	_
24-12	2692-2694	to	substance[177]	giv[177]	_	_
24-13	2695-2697	pH	substance[177]|abstract	giv[177]|new	_	_
24-14	2698-2701	and	substance[177]	giv[177]	_	_
24-15	2702-2713	temperature	substance[177]|abstract	giv[177]|new	_	_
24-16	2714-2715	.	_	_	_	_

#Text=Through the synthesis of short peptides with various amino acid sequences the Miller group are studying the self-assembly of Beta sheets . [ 15 ]
25-1	2716-2723	Through	_	_	_	_
25-2	2724-2727	the	event[180]	new[180]	_	_
25-3	2728-2737	synthesis	event[180]	new[180]	_	_
25-4	2738-2740	of	event[180]	new[180]	_	_
25-5	2741-2746	short	event[180]|substance[181]	new[180]|giv[181]	_	_
25-6	2747-2755	peptides	event[180]|substance[181]	new[180]|giv[181]	_	_
25-7	2756-2760	with	event[180]|substance[181]	new[180]|giv[181]	_	_
25-8	2761-2768	various	event[180]|substance[181]|abstract[183]	new[180]|giv[181]|new[183]	_	_
25-9	2769-2774	amino	event[180]|substance[181]|substance[182]|abstract[183]	new[180]|giv[181]|new[182]|new[183]	_	_
25-10	2775-2779	acid	event[180]|substance[181]|substance[182]|abstract[183]	new[180]|giv[181]|new[182]|new[183]	_	_
25-11	2780-2789	sequences	event[180]|substance[181]|abstract[183]	new[180]|giv[181]|new[183]	_	_
25-12	2790-2793	the	organization[185]	giv[185]	coref|ana	25-12[185_0]|26-1[0_185]
25-13	2794-2800	Miller	organization|organization[185]	giv|giv[185]	_	_
25-14	2801-2806	group	organization[185]	giv[185]	_	_
25-15	2807-2810	are	_	_	_	_
25-16	2811-2819	studying	_	_	_	_
25-17	2820-2823	the	abstract[186]	giv[186]	_	_
25-18	2824-2837	self-assembly	abstract[186]	giv[186]	_	_
25-19	2838-2840	of	abstract[186]	giv[186]	_	_
25-20	2841-2845	Beta	abstract[186]|person|object[188]	giv[186]|new|new[188]	_	_
25-21	2846-2852	sheets	abstract[186]|object[188]	giv[186]|new[188]	_	_
25-22	2853-2854	.	_	_	_	_
25-23	2855-2856	[	_	_	_	_
25-24	2857-2859	15	abstract	new	_	_
25-25	2860-2861	]	_	_	_	_

#Text=She has developed a biocompatible , biodegradable cardiac patch , created from a thick porous scaffold coated with a material that mimics the extracellular matrix . [ 16 ]
26-1	2862-2865	She	organization	giv	ana	27-1
26-2	2866-2869	has	_	_	_	_
26-3	2870-2879	developed	_	_	_	_
26-4	2880-2881	a	object[192]	new[192]	_	_
26-5	2882-2895	biocompatible	object[192]	new[192]	_	_
26-6	2896-2897	,	object[192]	new[192]	_	_
26-7	2898-2911	biodegradable	object[192]	new[192]	_	_
26-8	2912-2919	cardiac	substance|object[192]	new|new[192]	_	_
26-9	2920-2925	patch	object[192]	new[192]	_	_
26-10	2926-2927	,	object[192]	new[192]	_	_
26-11	2928-2935	created	object[192]	new[192]	_	_
26-12	2936-2940	from	object[192]	new[192]	_	_
26-13	2941-2942	a	object[192]|object[193]	new[192]|new[193]	_	_
26-14	2943-2948	thick	object[192]|object[193]	new[192]|new[193]	_	_
26-15	2949-2955	porous	object[192]|object[193]	new[192]|new[193]	_	_
26-16	2956-2964	scaffold	object[192]|object[193]	new[192]|new[193]	_	_
26-17	2965-2971	coated	object[192]|object[193]	new[192]|new[193]	_	_
26-18	2972-2976	with	object[192]|object[193]	new[192]|new[193]	_	_
26-19	2977-2978	a	object[192]|object[193]|substance[194]	new[192]|new[193]|giv[194]	_	_
26-20	2979-2987	material	object[192]|object[193]|substance[194]	new[192]|new[193]|giv[194]	_	_
26-21	2988-2992	that	object[192]|object[193]|substance[194]	new[192]|new[193]|giv[194]	_	_
26-22	2993-2999	mimics	object[192]|object[193]|substance[194]	new[192]|new[193]|giv[194]	_	_
26-23	3000-3003	the	object[192]|object[193]|substance[194]|substance[195]	new[192]|new[193]|giv[194]|new[195]	_	_
26-24	3004-3017	extracellular	object[192]|object[193]|substance[194]|substance[195]	new[192]|new[193]|giv[194]|new[195]	_	_
26-25	3018-3024	matrix	object[192]|object[193]|substance[194]|substance[195]	new[192]|new[193]|giv[194]|new[195]	_	_
26-26	3025-3026	.	_	_	_	_
26-27	3027-3028	[	_	_	_	_
26-28	3029-3031	16	abstract	new	_	_
26-29	3032-3033	]	_	_	_	_

#Text=She also studies the degradation mechanism of these materials . [ 17 ]
27-1	3034-3037	She	organization	giv	coref	28-1
27-2	3038-3042	also	_	_	_	_
27-3	3043-3050	studies	_	_	_	_
27-4	3051-3054	the	abstract[199]	new[199]	_	_
27-5	3055-3066	degradation	abstract|abstract[199]	new|new[199]	_	_
27-6	3067-3076	mechanism	abstract[199]	new[199]	_	_
27-7	3077-3079	of	abstract[199]	new[199]	_	_
27-8	3080-3085	these	abstract[199]|substance[200]	new[199]|giv[200]	_	_
27-9	3086-3095	materials	abstract[199]|substance[200]	new[199]|giv[200]	_	_
27-10	3096-3097	.	_	_	_	_
27-11	3098-3099	[	_	_	_	_
27-12	3100-3102	17	abstract	new	_	_
27-13	3103-3104	]	_	_	_	_

#Text=Miller was awarded a small grant from the University of Manchester to develop the synthesis of peptide-based hydrogels . [ 18 ]
28-1	3105-3111	Miller	organization	giv	ana	29-9
28-2	3112-3115	was	_	_	_	_
28-3	3116-3123	awarded	_	_	_	_
28-4	3124-3125	a	abstract[203]	new[203]	_	_
28-5	3126-3131	small	abstract[203]	new[203]	_	_
28-6	3132-3137	grant	abstract[203]	new[203]	_	_
28-7	3138-3142	from	abstract[203]	new[203]	_	_
28-8	3143-3146	the	abstract[203]|organization[204]	new[203]|giv[204]	coref	51-12[323_204]
28-9	3147-3157	University	abstract[203]|organization[204]	new[203]|giv[204]	_	_
28-10	3158-3160	of	abstract[203]|organization[204]	new[203]|giv[204]	_	_
28-11	3161-3171	Manchester	abstract[203]|organization[204]|place	new[203]|giv[204]|giv	coref	31-13
28-12	3172-3174	to	_	_	_	_
28-13	3175-3182	develop	_	_	_	_
28-14	3183-3186	the	abstract[206]	new[206]	_	_
28-15	3187-3196	synthesis	abstract[206]	new[206]	_	_
28-16	3197-3199	of	abstract[206]	new[206]	_	_
28-17	3200-3213	peptide-based	abstract[206]|substance[207]	new[206]|new[207]	coref	29-1[210_207]
28-18	3214-3223	hydrogels	abstract[206]|substance[207]	new[206]|new[207]	_	_
28-19	3224-3225	.	_	_	_	_
28-20	3226-3227	[	_	_	_	_
28-21	3228-3230	18	abstract	new	_	_
28-22	3231-3232	]	_	_	_	_

#Text=The synthetic peptide hydrogels were so successful that she set up the spin-out company PeptiGelDesign , a group which worked to commercialise hydrogel technologies . [ 19 ]
29-1	3233-3236	The	substance[210]	giv[210]	coref	31-21[230_210]
29-2	3237-3246	synthetic	substance[210]	giv[210]	_	_
29-3	3247-3254	peptide	place|substance[210]	new|giv[210]	_	_
29-4	3255-3264	hydrogels	substance[210]	giv[210]	_	_
29-5	3265-3269	were	_	_	_	_
29-6	3270-3272	so	_	_	_	_
29-7	3273-3283	successful	_	_	_	_
29-8	3284-3288	that	_	_	_	_
29-9	3289-3292	she	organization	giv	coref	29-17[214_0]
29-10	3293-3296	set	_	_	_	_
29-11	3297-3299	up	_	_	_	_
29-12	3300-3303	the	organization[212]|abstract[213]	new[212]|new[213]	coref|coref	31-7[0_213]|31-9[226_212]
29-13	3304-3312	spin-out	organization[212]|abstract[213]	new[212]|new[213]	_	_
29-14	3313-3320	company	organization[212]|abstract[213]	new[212]|new[213]	_	_
29-15	3321-3335	PeptiGelDesign	abstract[213]	new[213]	_	_
29-16	3336-3337	,	_	_	_	_
29-17	3338-3339	a	organization[214]	giv[214]	coref	51-1[0_214]
29-18	3340-3345	group	organization[214]	giv[214]	_	_
29-19	3346-3351	which	organization[214]	giv[214]	_	_
29-20	3352-3358	worked	organization[214]	giv[214]	_	_
29-21	3359-3361	to	organization[214]	giv[214]	_	_
29-22	3362-3375	commercialise	organization[214]	giv[214]	_	_
29-23	3376-3384	hydrogel	organization[214]|substance|abstract[216]	giv[214]|new|new[216]	_	_
29-24	3385-3397	technologies	organization[214]|abstract[216]	giv[214]|new[216]	_	_
29-25	3398-3399	.	_	_	_	_
29-26	3400-3401	[	_	_	_	_
29-27	3402-3404	19	abstract	new	coref	30-14
29-28	3405-3406	]	_	_	_	_

#Text=Since 2008 PeptiGelDesig n have raised over £6 million in funding . [ 19 ]
30-1	3407-3412	Since	_	_	_	_
30-2	3413-3417	2008	time	new	coref	45-1
30-3	3418-3431	PeptiGelDesig	organization[219]	new[219]	_	_
30-4	3432-3433	n	organization[219]	new[219]	_	_
30-5	3434-3438	have	_	_	_	_
30-6	3439-3445	raised	_	_	_	_
30-7	3446-3450	over	abstract[220]	new[220]	_	_
30-8	3451-3453	£6	abstract[220]	new[220]	_	_
30-9	3454-3461	million	abstract[220]	new[220]	_	_
30-10	3462-3464	in	_	_	_	_
30-11	3465-3472	funding	abstract	new	_	_
30-12	3473-3474	.	_	_	_	_
30-13	3475-3476	[	_	_	_	_
30-14	3477-3479	19	abstract	giv	_	_
30-15	3480-3481	]	_	_	_	_

#Text=Recognising the reach and potential of PeptiGelDesign , the company relaunched as Manchester BIOGEL in 2018 , continuing to offer peptide-based hydrogels amongst other biomaterials . [ 20 ]
31-1	3482-3493	Recognising	_	_	_	_
31-2	3494-3497	the	abstract[223]	new[223]	_	_
31-3	3498-3503	reach	abstract[223]	new[223]	_	_
31-4	3504-3507	and	_	_	_	_
31-5	3508-3517	potential	abstract[224]	new[224]	_	_
31-6	3518-3520	of	abstract[224]	new[224]	_	_
31-7	3521-3535	PeptiGelDesign	abstract[224]|abstract	new[224]|giv	_	_
31-8	3536-3537	,	_	_	_	_
31-9	3538-3541	the	organization[226]	giv[226]	_	_
31-10	3542-3549	company	organization[226]	giv[226]	_	_
31-11	3550-3560	relaunched	_	_	_	_
31-12	3561-3563	as	_	_	_	_
31-13	3564-3574	Manchester	place|organization[228]	giv|new[228]	coref	51-15
31-14	3575-3581	BIOGEL	organization[228]	new[228]	_	_
31-15	3582-3584	in	_	_	_	_
31-16	3585-3589	2018	time	new	_	_
31-17	3590-3591	,	_	_	_	_
31-18	3592-3602	continuing	_	_	_	_
31-19	3603-3605	to	_	_	_	_
31-20	3606-3611	offer	_	_	_	_
31-21	3612-3625	peptide-based	substance[230]	giv[230]	coref	32-1[233_230]
31-22	3626-3635	hydrogels	substance[230]	giv[230]	_	_
31-23	3636-3643	amongst	_	_	_	_
31-24	3644-3649	other	substance[231]	new[231]	_	_
31-25	3650-3662	biomaterials	substance[231]	new[231]	_	_
31-26	3663-3664	.	_	_	_	_
31-27	3665-3666	[	_	_	_	_
31-28	3667-3669	20	abstract	new	coref	32-22
31-29	3670-3671	]	_	_	_	_

#Text=The hydrogels can be used to improve the quality of drug toxicity testing , DNA sensing and regenerative medicine . [ 20 ] [ 21 ]
32-1	3672-3675	The	substance[233]	giv[233]	_	_
32-2	3676-3685	hydrogels	substance[233]	giv[233]	_	_
32-3	3686-3689	can	_	_	_	_
32-4	3690-3692	be	_	_	_	_
32-5	3693-3697	used	_	_	_	_
32-6	3698-3700	to	_	_	_	_
32-7	3701-3708	improve	_	_	_	_
32-8	3709-3712	the	abstract[234]	new[234]	_	_
32-9	3713-3720	quality	abstract[234]	new[234]	_	_
32-10	3721-3723	of	abstract[234]	new[234]	_	_
32-11	3724-3728	drug	abstract[234]|substance|abstract[237]	new[234]|new|new[237]	_	_
32-12	3729-3737	toxicity	abstract[234]|abstract|abstract[237]	new[234]|new|new[237]	_	_
32-13	3738-3745	testing	abstract[234]|abstract[237]	new[234]|new[237]	_	_
32-14	3746-3747	,	abstract[234]	new[234]	_	_
32-15	3748-3751	DNA	abstract[234]|abstract|abstract[239]	new[234]|new|new[239]	_	_
32-16	3752-3759	sensing	abstract[234]|abstract[239]	new[234]|new[239]	_	_
32-17	3760-3763	and	abstract[234]	new[234]	_	_
32-18	3764-3776	regenerative	abstract[234]|abstract[240]	new[234]|new[240]	_	_
32-19	3777-3785	medicine	abstract[234]|abstract[240]	new[234]|new[240]	_	_
32-20	3786-3787	.	_	_	_	_
32-21	3788-3789	[	_	_	_	_
32-22	3790-3792	20	abstract	giv	_	_
32-23	3793-3794	]	_	_	_	_
32-24	3795-3796	[	_	_	_	_
32-25	3797-3799	21	abstract	new	_	_
32-26	3800-3801	]	_	_	_	_

#Text=Awards and honours
33-1	3802-3808	Awards	abstract|abstract[244]	new|new[244]	coref|coref	34-1[247_0]|34-1[248_244]
33-2	3809-3812	and	abstract[244]	new[244]	_	_
33-3	3813-3820	honours	abstract[244]|abstract	new[244]|new	coref	34-4

#Text=Her awards and honours include ;
34-1	3821-3824	Her	person|abstract[247]|abstract[248]	acc|giv[247]|giv[248]	_	_
34-2	3825-3831	awards	abstract[247]|abstract[248]	giv[247]|giv[248]	_	_
34-3	3832-3835	and	abstract[248]	giv[248]	_	_
34-4	3836-3843	honours	abstract[248]|abstract	giv[248]|giv	coref	36-7
34-5	3844-3851	include	_	_	_	_
34-6	3852-3853	;	_	_	_	_

#Text=1995 University of Strathclyde William Marr Dux Award
35-1	3854-3858	1995	time|organization[251]|abstract[254]	new|new[251]|new[254]	coref	36-2[259_254]
35-2	3859-3869	University	organization[251]|abstract[254]	new[251]|new[254]	_	_
35-3	3870-3872	of	organization[251]|abstract[254]	new[251]|new[254]	_	_
35-4	3873-3884	Strathclyde	organization[251]|person|abstract[254]	new[251]|giv|new[254]	coref	36-4
35-5	3885-3892	William	place[253]|abstract[254]	new[253]|new[254]	_	_
35-6	3893-3897	Marr	place[253]|abstract[254]	new[253]|new[254]	_	_
35-7	3898-3901	Dux	place[253]|abstract[254]	new[253]|new[254]	_	_
35-8	3902-3907	Award	abstract[254]	new[254]	_	_

#Text=1996 University of Strathclyde Dean 's Honours Award [ 22 ]
36-1	3908-3912	1996	_	_	_	_
36-2	3913-3923	University	organization[255]|person[257]|abstract[259]	new[255]|new[257]|giv[259]	coref|coref	38-1[262_255]|38-1[267_259]
36-3	3924-3926	of	organization[255]|person[257]|abstract[259]	new[255]|new[257]|giv[259]	_	_
36-4	3927-3938	Strathclyde	organization[255]|person|person[257]|abstract[259]	new[255]|giv|new[257]|giv[259]	coref	38-3
36-5	3939-3943	Dean	person[257]|abstract[259]	new[257]|giv[259]	_	_
36-6	3944-3946	's	person[257]|abstract[259]	new[257]|giv[259]	_	_
36-7	3947-3954	Honours	abstract|abstract[259]	giv|giv[259]	_	_
36-8	3955-3960	Award	abstract[259]	giv[259]	_	_
36-9	3961-3962	[	_	_	_	_
36-10	3963-3965	22	abstract	new	coref	38-9
36-11	3966-3967	]	_	_	_	_

#Text=1996
37-1	3968-3972	1996	time	new	_	_

#Text=University of Strathclyde Hackman Scholarship Research Award [ 22 ]
38-1	3973-3983	University	organization[262]|abstract[267]	giv[262]|giv[267]	coref	44-14[0_267]
38-2	3984-3986	of	organization[262]|abstract[267]	giv[262]|giv[267]	_	_
38-3	3987-3998	Strathclyde	organization[262]|person|abstract[267]	giv[262]|giv|giv[267]	coref	39-2[269_0]
38-4	3999-4006	Hackman	person|abstract[265]|abstract[267]	new|new[265]|giv[267]	_	_
38-5	4007-4018	Scholarship	abstract[265]|abstract[267]	new[265]|giv[267]	_	_
38-6	4019-4027	Research	organization|abstract[267]	giv|giv[267]	coref	41-4[278_0]
38-7	4028-4033	Award	abstract[267]	giv[267]	_	_
38-8	4034-4035	[	_	_	_	_
38-9	4036-4038	22	abstract	giv	coref	39-8
38-10	4039-4040	]	_	_	_	_

#Text=1997 Sir George Beilby Memorial Medal [ 22 ]
39-1	4041-4045	1997	_	_	_	_
39-2	4046-4049	Sir	person[269]|object[271]	giv[269]|new[271]	coref	47-1[306_271]
39-3	4050-4056	George	person[269]|object[271]	giv[269]|new[271]	_	_
39-4	4057-4063	Beilby	person[269]|object[271]	giv[269]|new[271]	_	_
39-5	4064-4072	Memorial	place|object[271]	new|new[271]	_	_
39-6	4073-4078	Medal	object[271]	new[271]	_	_
39-7	4079-4080	[	_	_	_	_
39-8	4081-4083	22	abstract	giv	coref	40-8
39-9	4084-4085	]	_	_	_	_

#Text=1999 Imperial Chemical Industries -Dupont Prize [ 22 ]
40-1	4086-4090	1999	_	_	_	_
40-2	4091-4099	Imperial	organization[273]|object[274]	new[273]|new[274]	coref	48-2[309_274]
40-3	4100-4108	Chemical	organization[273]|object[274]	new[273]|new[274]	_	_
40-4	4109-4119	Industries	organization[273]|object[274]	new[273]|new[274]	_	_
40-5	4120-4127	-Dupont	object[274]	new[274]	_	_
40-6	4128-4133	Prize	object[274]	new[274]	_	_
40-7	4134-4135	[	_	_	_	_
40-8	4136-4138	22	abstract	giv	coref	41-11
40-9	4139-4140	]	_	_	_	_

#Text=2001 New Hall Junior Research Fellowship [ 23 ] [ 22 ]
41-1	4141-4145	2001	_	_	_	_
41-2	4146-4149	New	person|place[277]|abstract[279]	new|giv[277]|new[279]	coref	42-2[284_279]
41-3	4150-4154	Hall	place[277]|abstract[279]	giv[277]|new[279]	_	_
41-4	4155-4161	Junior	organization[278]|abstract[279]	giv[278]|new[279]	coref	49-5[315_278]
41-5	4162-4170	Research	organization[278]|abstract[279]	giv[278]|new[279]	_	_
41-6	4171-4181	Fellowship	abstract[279]	new[279]	_	_
41-7	4182-4183	[	_	_	_	_
41-8	4184-4186	23	abstract	new	coref	52-7
41-9	4187-4188	]	_	_	_	_
41-10	4189-4190	[	_	_	_	_
41-11	4191-4193	22	abstract	giv	_	_
41-12	4194-4195	]	_	_	_	_

#Text=2004 Exxon Mobil Teaching Fellowship [ 24 ]
42-1	4196-4200	2004	_	_	_	_
42-2	4201-4206	Exxon	organization[282]|abstract[284]	new[282]|giv[284]	_	_
42-3	4207-4212	Mobil	organization[282]|abstract[284]	new[282]|giv[284]	_	_
42-4	4213-4221	Teaching	abstract|abstract[284]	new|giv[284]	_	_
42-5	4222-4232	Fellowship	abstract[284]	giv[284]	_	_
42-6	4233-4234	[	_	_	_	_
42-7	4235-4237	24	abstract	new	_	_
42-8	4238-4239	]	_	_	_	_

#Text=2008 Institute of Physics
43-1	4240-4244	2008	_	_	_	_
43-2	4245-4254	Institute	organization[286]	new[286]	_	_
43-3	4255-4257	of	organization[286]	new[286]	_	_
43-4	4258-4265	Physics	organization[286]|abstract	new[286]|new	coref	44-1[289_0]

#Text=Polymer Physics Group and American Physical Society Division of Polymer Physics Young Researchers Award [ 25 ]
44-1	4266-4273	Polymer	person|abstract[289]|organization[290]	new|giv[289]|giv[290]	coref|coref|coref	44-10|44-10[295_289]|47-1[303_290]
44-2	4274-4281	Physics	abstract[289]|organization[290]	giv[289]|giv[290]	_	_
44-3	4282-4287	Group	organization[290]	giv[290]	_	_
44-4	4288-4291	and	_	_	_	_
44-5	4292-4300	American	organization[292]|organization[293]	new[292]|new[293]	coref	46-1[300_292]
44-6	4301-4309	Physical	substance|organization[292]|organization[293]	new|new[292]|new[293]	_	_
44-7	4310-4317	Society	organization[292]|organization[293]	new[292]|new[293]	_	_
44-8	4318-4326	Division	organization[293]	new[293]	_	_
44-9	4327-4329	of	organization[293]	new[293]	_	_
44-10	4330-4337	Polymer	organization[293]|person|abstract[295]	new[293]|giv|giv[295]	_	_
44-11	4338-4345	Physics	organization[293]|abstract[295]	new[293]|giv[295]	_	_
44-12	4346-4351	Young	person[296]	new[296]	coref	47-1[305_296]
44-13	4352-4363	Researchers	person[296]	new[296]	_	_
44-14	4364-4369	Award	abstract	giv	coref	49-4[316_0]
44-15	4370-4371	[	_	_	_	_
44-16	4372-4374	25	abstract	new	_	_
44-17	4375-4376	]	_	_	_	_

#Text=2008
45-1	4377-4381	2008	time	giv	_	_

#Text=Royal Society of Chemistry
46-1	4382-4387	Royal	organization[300]	giv[300]	_	_
46-2	4388-4395	Society	organization[300]	giv[300]	_	_
46-3	4396-4398	of	organization[300]	giv[300]	_	_
46-4	4399-4408	Chemistry	organization[300]|abstract	giv[300]|giv	_	_

#Text=Macro Group UK Young Researchers Medal [ 26 ]
47-1	4409-4414	Macro	person|organization[303]|person[305]|object[306]	new|giv[303]|giv[305]|giv[306]	ana	52-1[0_305]
47-2	4415-4420	Group	organization[303]|person[305]|object[306]	giv[303]|giv[305]|giv[306]	_	_
47-3	4421-4423	UK	place|person[305]|object[306]	new|giv[305]|giv[306]	_	_
47-4	4424-4429	Young	person[305]|object[306]	giv[305]|giv[306]	_	_
47-5	4430-4441	Researchers	person[305]|object[306]	giv[305]|giv[306]	_	_
47-6	4442-4447	Medal	object[306]	giv[306]	_	_
47-7	4448-4449	[	_	_	_	_
47-8	4450-4452	26	abstract	new	_	_
47-9	4453-4454	]	_	_	_	_

#Text=2014 Philip Leverhulme Prize for Engineering [ 27 ]
48-1	4455-4459	2014	_	_	_	_
48-2	4460-4466	Philip	person[308]|object[309]	new[308]|giv[309]	_	_
48-3	4467-4477	Leverhulme	person[308]|object[309]	new[308]|giv[309]	_	_
48-4	4478-4483	Prize	object[309]	giv[309]	_	_
48-5	4484-4487	for	object[309]	giv[309]	_	_
48-6	4488-4499	Engineering	object[309]|abstract	giv[309]|giv	_	_
48-7	4500-4501	[	_	_	_	_
48-8	4502-4504	27	abstract	new	_	_
48-9	4505-4506	]	_	_	_	_

#Text=2014 Finalist for the WISE Campaign Research Award [ 28 ]
49-1	4507-4511	2014	person[312]	new[312]	_	_
49-2	4512-4520	Finalist	person[312]	new[312]	_	_
49-3	4521-4524	for	person[312]	new[312]	_	_
49-4	4525-4528	the	person[312]|abstract[316]	new[312]|giv[316]	_	_
49-5	4529-4533	WISE	person[312]|organization|abstract[314]|organization[315]|abstract[316]	new[312]|new|new[314]|giv[315]|giv[316]	_	_
49-6	4534-4542	Campaign	person[312]|abstract[314]|organization[315]|abstract[316]	new[312]|new[314]|giv[315]|giv[316]	_	_
49-7	4543-4551	Research	person[312]|organization[315]|abstract[316]	new[312]|giv[315]|giv[316]	_	_
49-8	4552-4557	Award	person[312]|abstract[316]	new[312]|giv[316]	_	_
49-9	4558-4559	[	_	_	_	_
49-10	4560-4562	28	abstract	new	_	_
49-11	4563-4564	]	_	_	_	_

#Text=Personal life
50-1	4565-4573	Personal	abstract[318]	new[318]	_	_
50-2	4574-4578	life	abstract[318]	new[318]	_	_

#Text=Miller is married to Alberto Saiani , a materials scientist at the University of Manchester .
51-1	4579-4585	Miller	organization	giv	_	_
51-2	4586-4588	is	_	_	_	_
51-3	4589-4596	married	_	_	_	_
51-4	4597-4599	to	_	_	_	_
51-5	4600-4607	Alberto	person[320]	new[320]	appos	51-8[322_320]
51-6	4608-4614	Saiani	person[320]	new[320]	_	_
51-7	4615-4616	,	_	_	_	_
51-8	4617-4618	a	person[322]	giv[322]	_	_
51-9	4619-4628	materials	substance|person[322]	new|giv[322]	_	_
51-10	4629-4638	scientist	person[322]	giv[322]	_	_
51-11	4639-4641	at	person[322]	giv[322]	_	_
51-12	4642-4645	the	person[322]|organization[323]	giv[322]|giv[323]	_	_
51-13	4646-4656	University	person[322]|organization[323]	giv[322]|giv[323]	_	_
51-14	4657-4659	of	person[322]|organization[323]	giv[322]|giv[323]	_	_
51-15	4660-4670	Manchester	person[322]|organization[323]|place	giv[322]|giv[323]|giv	_	_
51-16	4671-4672	.	_	_	_	_

#Text=They have three children . [ 23 ]
52-1	4673-4677	They	person	giv	_	_
52-2	4678-4682	have	_	_	_	_
52-3	4683-4688	three	person[326]	new[326]	_	_
52-4	4689-4697	children	person[326]	new[326]	_	_
52-5	4698-4699	.	_	_	_	_
52-6	4700-4701	[	_	_	_	_
52-7	4702-4704	23	abstract	giv	_	_
52-8	4705-4706	]	_	_	_	_
